Nevertheless, the data surrounding the safety and tolerability of anti-basigin may have implications beyond SARS-CoV-2, as these trials could inform the use of anti-basigin as a malaria prophylactic regardless of its effectiveness in reducing mortality and morbidity due to COVID-19. Here, BSG is linked to malaria.